Hospital registry of acute miocardial infarction in Santa Clara
Keywords:
acute myocardial infarction, epidemiology, cholesterol, high blood pressure, cardiac catheterizationAbstract
Introduction and objectives: In Cuba, the vital statistics of morbi-mortality due to acute myocardial infarction come from small health areas. The objective of this study was to identify the main characteristics and hospital management of patients with myocardial infarction, through a hospital registry of infarctions. Methods: The cases of acute myocardial infarction in patients between 45 and 74 years of age, from Santa Clara, during 2007 and 2008, were monitored. The information sources were: hospital discharge records, hospital registry of myocardial infarction, death certificates and nosocomial autopsy records. The MONICA methodology was used (Monitoring Trends and Determinants in Cardiovascular Disease Project). Results: a total of 297 patients with acute myocardial infarction were registered; 62,7 percent of males and 46,8 percent of women received reperfusion treatment. The hospital deaths in males and women were 25,3 percent and 45 percent respectively. The variables related to a higher mortality were: age, female sex, a high cardiac frequency, anterior-wall infarction, a high creatinine level, as well as individual antecedents of ischemic heart disease and diabetes mellitus. On the other hand, the treatments with fibrinolitics and/or beta-blockers were inversely proportional to mortality. Conclusions: There was a high prevalence of unknown dyslipidemia and hospital death within 28 days; as well as little use of invasive strategies. Systolic hypertension at the time of admission was related with a better prognosis.
Downloads
References
1. World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk. Geneva: WHO Library; 2007.
2. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14 Suppl 2:S1-113.
3. Allender S, Scharbotough P, Peto V, Rayner M, Leal J, Luengo-Fernández R, et al. European Cardiovascular disease statistics: 2008 edition. London: British Heart Foundation; 2008.
4. Marrugat J, Elosua R, Gil M. Riesgo multifactorial. Epidemiología de la enfermedad coranaria. En: Badimon L, Bosch X, Elosua R, Gil M, Marrugat J, Martínez-González J. Síndrome coronario agudo. Madrid: Ed. Ergon 1999; 101-2.
5. Ordúñez P, Cooper R, Espinosa A, Iraola M, Bernal JL, La Rosa Y. Enfermedades cardiovasculares en Cuba: determinantes para una epidemia y desafíos para la prevención y control. Rev Cubana Salud Pública. 2005; 31:1-22.
6. Ministerio de Salud Pública. Anuario estadístico del año 2007.La Habana. Dirección nacional de registros médicos y estadísticas en salud. Disponible en: http://bvs.sld.cu/cgi-bin/wxis/anuario/?IsisScript=anuario/iah.xis&tag5003=anuario&tag5021=e&tag6000=B&tag501 3=GUEST&tag5022=2007
7. Situación de Salud en Cuba. Indicadores Básicos 2003. Disponible en: www.dne.sld.cu (fecha de acceso 24 de junio del 2007).
8. Cabadés A. El registro REGICOR y la epidemiología del infarto de miocardio en España: se hace camino al andar. Rev Esp Cardiol. 2007;60(4):342-5.
9. Ríos Massabot NE, Fernández Viera RM, Jorge Pérez ER. Los registros médicos en Cuba. Rev Cub Salud Pública 2005;31(4) 345-52.
10. Sans S, Puig de fabregas A, Paluzie G, Monterde D, Balaguer-Vintró I. Increasing trends of acute myocardial infarction in Spain: the MONICA-Catalonia study. Eur Heart J. 2005;26:505-15
11. Arós F, Cuñat J, Loma-Osorio A, Torrado E, Bosch X, Rodríguez J, et al. Manejo del infarto de miocardio en España en el año 2000. El estudio PRIAMHO II. Rev Esp Cardiol. 2003;56:1165-73
12. Ferreira-González I, Permanyer-Miralda G, Marrugat J, Heras M, Cuñat J, Civeira E, et al. Estudio MASCARA (Manejo del Síndrome Coronario Agudo. Registro Actualizado). Resultados globales. Rev Esp Cardiol. 2008;61(8):803-16.
13. Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG, et al. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2004;93:288-93.
14. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292:2096-104.
15. Bueno H, Bardají A, Fernández-Ortiz A, Marrugat J, Martí H, Heras M. Descripción del Estado de los Síndromes Coronarios Agudos en un Registro Temporal ESpañol. Estudio DESCARTES. Rev Esp Cardiol. 2005;58:242-50.
16. Delfín Ballesteros CA, Rodríguez Martorell F, Domínguez Torres A, Rodríguez Alvarez A, De León Llaguno N. Infarto agudo del miocardio en la unidad de cuidados intensivos de emergencias. Rev Cub Med Int Emerg 2006;5(4):571-577
17. Gil M, Martí H, Elosúa R, Grau M, Sala J, Masiá R, et al. Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999. Rev Esp Cardiol. 2007;60(4):349-56.
18. Cicoria M, Maggioni AP, Latini R, Barlera S, Carreta E, Janosi A, et al. Body mass index, prognosis and mode of death in chronic heart failure: results from the Valsartan Heart Failure Trial. Eur Heart J. 2007;9:397-402
19. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004; 43:1439-1444
20. Elosua R, Vega G, Rohlf I, Aldasorod E, Navarro C, Cabades A, et al. Smoking and myocardial infarction case-fatality: hospital and population approach.Eur J Cardiovasc Prev Rehabil. 2007;14:561-567
21. Fonarow GC, Srikanthan P,Costanzo MR, Cintron GB, Lopatin M, et al. An obesity paradox in acute heart failure: Analysis of body mass index and inhospital mortality for 108927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007;153:74-81.
22. Sagar US, Ahmed MM, Adams S, Whellan DJ. Does Body Mass Index Really Matter in the Management of Heart Failure? Cardiology in Review 2008;16: 124-8.
23. Zamora E, Lupón J, Urrutia A, González B, Mas D, Pascual T. ¿El índice de masa corporal influye en la mortalidad de los pacientes con insuficiencia cardiaca? Rev Esp Cardiol. 2007;60:1027-34
24. Artham SM, Ventura HO. Insuficiencia cardiaca y la «paradoja de la obesidad»: la historia continúa. Rev Esp Cardiol. 2007;60:1013-7.
25. Morales Salinas A. Paradoja de la obesidad y suceptibilidad del bajo peso. Rev Esp Cardiol. 2008;61(6):653
26. Zamora E, Lupón J. Respuesta. Rev Esp Cardiol. 2008;61:654
27. Artham SM, Ventura HO. Respuesta. Rev Esp Cardiol. 2008;61:654-6.
28. Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: A meta-analysis. Am Heart J 2008;156:13-22.
29. Morales Salinas A, Lopez G, Ramos R. Obesity paradox?. Letter to Editor. Am Heart J. 2008;155:e1.
30. Morales Salinas A, Coca A. Obesidad, actividad física y riesgo cardiovascular: clasificación ergoantropométrica, variables farmacológicas, biomarcadores y "paradoja del obeso" Med Clin (Barc).2010;134(11):492-8.
31. Rodríguez-Padial L, Lázaro-Salvador M, Santos-González B. Importancia pronóstica de la frecuencia cardíaca en la población general y en pacientes con enfermedad arterial coronaria e hipertensión arterial. Posibles mecanismos. Rev Esp Cardiol Supl. 2007;7:2D-8D.
32. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005;26:967-74.
33. López-Sendón J, López de Sá E. Reducción de la frecuencia cardíaca. Otras oportunidades terapéuticas. Rev Esp Cardiol Supl. 2007;7:53D-57D.
34. López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H. Documento de Consenso de Expertos sobre bloqueadores de los receptores B-adrenérgicos. Rev Esp Cardiol. 2005;58:65-90.
35. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Manejo del infarto agudo de miocardio en pacientes con elevación persistente del segmento ST. Rev Esp Cardiol. 2009;62(3):e1-e47.
36. Brauwald E. Expanding indications for beta-blockers in heart failure. N Engl J Med, 2001; 344(22): 1711-12.
37. Danchin N, Coste P, Ferrières J, Steg P-G, Cottin Y, Blanchard D, et al, the FAST-MI Investigators. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the French Registry on Acute STElevation Myocardial Infarction (FAST-MI). Circulation. 2008;118:268-76.
38. Valdesuso Aguilar RM, Hidalgo Barrios C, León Díaz R, Pérez A. Tratamiento prehospitalario del infarto agudo del miocardio. Rev Cub Cardiol Cir Cardiovasc. 1997;11(1):20-8
39. Ramos Prevez O, Armaignac Ferrer G, Nápoles Riaño D, Hechavarría Soulary JC. Trombolisis e infarto agudo del miocardio en la Unidad de Cuidados Intensivos Hospital Clínico quirúrgico Docente Dr. Joaquín Castillo Duany. MEDISAN. 2000;4(2):22-8.
40. Álvarez-León EE, Elosua R, Zamora A, Aldasoro E, Galcerá J, Vanaclocha H, et al. Recursos hospitalarios y letalidad por infarto de miocardio. Estudio IBERICA Rev Esp Cardiol 2004;57(6):514-23.
41. Gil M, Martí H, Elosúa R, Grau M, Sala J, Masiá R, et al. Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999. Rev Esp Cardiol. 2007;60(4):349-56.
42. Novella B, Alonso M, Rodriguez-Salvanés F, Susi R, Reviriego B, Escalante L, et al. Incidencia a diez años de infarto miocárdico fatal y no fatal en la población anciana de Madrid. Rev Esp Cardiol. 2008;61:1140-9.
43. Fiol M, Cabadés A, Sala, Marrugat J, Elosua R, Vega G. Variabilidad en el manejo hospitalario del infarto agudo de miocardio en España. Estudio IBERICA (Investigación, Búsqueda Específica y Registro de Isquemia Coronaria Aguda)* Rev Esp Cardiol 2001; 54: 443-452.
44. Sanz GA. Estratificación del riesgo en los síndromes coronarios agudos: un problema no resuelto. Rev Esp Cardiol. 2007;60(Supl 3):23-30.
45. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, Lemos JA, et al. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation. 2000;102:2031-2037.
46. Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, et al. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational 0bservational study (GRACE). BMJ. 2006;333:1091-4.
47. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835-42.
48. Sabatine MS, Antman EM. The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2003;41 Suppl S:89-95.
Downloads
Published
How to Cite
License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.